The current macro investing climate is one in which investors have plenty to consider. On the one hand, growth stocks continue to outperform as investors look for ways to capitalize on a surprisingly robust bull market. Yes, we've already seen plenty of history made in early 2026, with geopolitical issues and newfound ramped up tariff rhetoric recently sending the VIX back above 20 for the first time in months. However, I'm of the view that the choppiness we could see for the remainder of the year may outpa ...

古根海姆将强生的目标价从227美元上调至240美元，维持"买入"评级。(格隆汇) ...

Robotic surgical arm in a modern hospital room, highlighting medical technology driving healthcare stock rotation. Key Points Healthcare stocks rebounded in 2025, but select growth names are emerging outside traditional biotech. Medical technology and healthcare services offer recurring revenue and lower binary risk. Intuitive Surgical, Edwards Lifesciences, and IQVIA provide different paths to long-term healthcare growth. Interested in IQVIA Holdings Inc.? Here are five stocks we like better. Hea ...

Core Viewpoint - The Supreme Court of India upheld a landmark verdict against Johnson & Johnson (J&J) for its faulty ASR hip implant, highlighting the disparity in compensation awarded to Indian patients compared to those in the US [8][10][12]. Company Accountability - J&J was found culpable for the defective ASR hip implant, which caused severe health issues, including metallosis, with a failure rate of 37% over five years and up to 40% in seven years in some countries [12][13]. - The company has faced thousands of lawsuits globally for misleading marketing and delaying alerts about the product's harmful effects [12][13]. Compensation Disparity - J&J has paid over $4 billion in settlements in the US, with an average compensation of $300,000 per affected patient, while Indian patients received significantly lower amounts, with the highest compensation being ₹35 lakh (approximately $42,000) ordered by the NCDRC [10][11][12]. - The compensation offered by J&J to Indian patients was a flat ₹25 lakh, which was criticized as inadequate compared to settlements in the US [10][13]. Legal Challenges - The Indian legal framework lacks provisions for punitive damages or expansive class action settlements, which has resulted in lower compensation for affected patients compared to those in the US [20][21][23]. - J&J challenged the Indian government's proposed compensation formula, which could have awarded between ₹30 lakh and ₹1.2 crore based on the severity of injuries [16][17]. Patient Advocacy - Health activists and legal experts have criticized the Indian judicial system for not providing adequate compensation and for the lengthy legal process that has left many patients without relief [18][22][23]. - There is a call for greater sensitivity and proactivity from the government and judiciary to address the needs of affected patients [22].

LAS VEGAS, NEVADA - JANUARY 24: A detailed view of fight gloves during the UFC 324 event at T-Mobile Arena on January 24, 2026 in Las Vegas, Nevada. (Photo by Mike Roach/Zuffa LLC)Zuffa LLCHIGHLIGHTSA flyweight contender suffered a brutal first-round knockout on the UFC 324 prelims.The current 125-pound champion wasted no time trolling the defeated fighter on social media.The two have a violent history that makes the online exchange even more personal.Charles Johnson had a rough Saturday night. The perennia ...

Core Insights - The job market is experiencing significant challenges, particularly for those laid off due to automation and AI-driven changes in companies [2][12] - AI is being utilized in the job application process, both as a tool for job seekers and as a screening mechanism by employers, leading to a complex and often frustrating experience [12][13] Company Impact - Companies are increasingly automating workflows, resulting in layoffs and pushing employees back into a competitive job market [12] - The reliance on AI for screening applicants creates a barrier for job seekers, as they must navigate opaque criteria that may not favor them [12][13] Job Seeker Experience - The job search process has become tedious and draining, with many applicants feeling lost in the system, particularly when using platforms like LinkedIn [6][7] - AI-powered application platforms can assist job seekers by automating the application process, allowing them to focus on interview preparation and networking [9][10] - Despite the challenges, AI can provide significant advantages when used effectively, helping job seekers regain momentum in their job search [14]

Key Takeaways JNJ topped Q4 EPS and sales estimates, driven by strong growth in Innovative Medicines and MedTech segments.Johnson & Johnson expects higher 2026 cash flow on R&D, M&A investments, and multiple new drug launches.IHE offers diversified exposure to JNJ after its earnings surprise and brief post-report dip.Medtech giant Johnson & Johnson (JNJ) announced better-than-expected fourth-quarter 2025 results on Jan. 21, 2026. The company continued its streak of earnings beats and also beat on sales est ...

Company Overview - Goldman Sachs, founded in 1869, is the world's second-largest investment bank by revenue and ranks 55th on the Fortune 500 list of largest U.S. corporations by total revenue [1] - The firm offers a range of services including financing, advisory services, risk distribution, and hedging for institutional and corporate clients, maintaining its leadership in the investment landscape [1] Market Insights - Timothy Moe, Chief Head of APAC Equity Strategy at Goldman Sachs, highlighted a historical pattern of market corrections occurring every eight to nine months, indicating that the market is overdue for a correction [2] - The firm is increasingly focusing on the energy sector, predicting that while prices may remain flat or decline this year, they could rise starting in 2027 [2] Investment Recommendations - Goldman Sachs has identified five top stocks for investors to consider, particularly emphasizing two companies in the energy sector that are expected to perform well in the future [3] - The firm maintains its status as a premier financial institution, being the go-to bank for a wide range of financial needs over the past 15 years [4] Stock Highlights - **Brixmor Property Group**: This REIT offers a 4.31% dividend and has a target price of $32, indicating a 23% upside potential [5][7] - **Duke Energy**: An electric power and natural gas holding company with a 3.52% dividend and a target price of $141, representing a 20% gain from current levels [8][9] - **Hershey**: A snacks company with a 2.77% dividend and a target price of $220, suggesting a 21% potential increase [10][13] - **Johnson & Johnson**: A diversified healthcare company with a 2.31% dividend and a target price of $240, indicating a 16% upside [14][16] - **Valero Energy**: A multinational manufacturer of petroleum products with a 2.43% dividend and a target price of $197, representing a 19% gain [17][20]

Maybe there won't be any screaming about this stock. But there could be some buying.Johnson & Johnson (JNJ +0.22%) has been in business since 1886. The company has experienced significant success along the way. However, its share price has never been higher than the levels already achieved in the first few weeks of 2026. CEO Joaquin Duato said in J&J's fourth-quarter update earlier this week that 2025 "kicked off a new era of accelerated growth" for the company. Is the healthcare stock a screaming buy now? ...

格隆汇1月23日｜花旗将强生的目标价从232美元上调至250美元，维持"买入"评级。(格隆汇) ...